+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Central Lab Market by Service Type, Phase, Therapeutic Area, End-use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5887695
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Central Lab Market grew from USD 3.11 billion in 2023 to USD 3.38 billion in 2024. It is expected to continue growing at a CAGR of 9.25%, reaching USD 5.78 billion by 2030.

The Central Lab market plays a critical role in the clinical trials and drug development processes by providing essential laboratory services such as sample collection, analysis, and data management. This market's necessity stems from the increasing complexity and regulatory demands of clinical trials that require standardized and high-quality testing across multiple sites. Central Labs help streamline these processes by offering centralization and consistency in data, which is invaluable for ensuring scientific validity and regulatory compliance. Predominantly utilized in pharmaceutical and biotechnology sectors, Central Labs are integral in areas such as oncology, cardiovascular, and infectious disease research. Key growth factors for this market include the globalization of clinical trials, advancements in personalized medicine, and increasing R&D expenditures. Opportunities arise from innovation in lab automation, real-time data analytics, and artificial intelligence, which can enhance operational efficiency and accuracy.

However, the market faces limitations such as high operational costs, stringent regulatory requirements, and the challenge of maintaining data security. Moreover, the dynamic shifts in diagnostic technologies and the rise of decentralized trials pose both challenges and opportunities. It is crucial for Central Labs to adapt by investing in innovative solutions that enhance flexibility and data integration capabilities. Areas of innovation include the development of digital pathology, advanced biomarker analysis, and enhanced connectivity solutions for seamless data transfer. Research into AI-driven predictive analytics offers new avenues for improved decision-making and personalized treatment approaches. The nature of this market is increasingly competitive, with a growing emphasis on value-added services and technological integration. For sustained growth, companies should focus on collaborative partnerships, investment in cutting-edge technologies, and expanding operational footprints into emerging markets, ensuring they remain agile and responsive to industry trends.

Understanding Market Dynamics in the Central Lab Market

The Central Lab Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rise in the number of clinical trials and complexity of drug development activities
    • Government initiatives promoting precision medicine worldwide
  • Market Restraints
    • High cost of set-up and maintenance of central labs
  • Market Opportunities
    • Technological integrations and smart features in central labs
    • Investments for establishment and expansion of central labs
  • Market Challenges
    • Operational limitations and standardization complexities

Exploring Porter’s Five Forces for the Central Lab Market

Porter’s Five Forces framework further strengthens the insights of the Central Lab Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Central Lab Market

External macro-environmental factors deeply influence the performance of the Central Lab Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Central Lab Market

The Central Lab Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Central Lab Market

The Central Lab Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Central Lab Market, highlighting leading vendors and their innovative profiles. These include ACM Medical Laboratory, Inc., Almac Group, Cerba HealthCare, CROMSOURCE by ClinChoice, Cryoport, Inc., Eurofins Scientific SE, Exagen Inc., Frontage Laboratories, Inc., GBA Group, GCCL Co., Ltd., ICON PLC, InterlabCorp, Intertek Group PLC, IQVIA Inc., LabConnect, Inc., Laboratory Corporation of America Holdings, Lambda Therapeutic Research Ltd., Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd., MDS Pharma Services, Medicover AB, Medpace, Inc., MLM Medical Labs GmbH, Novotech Health Holdings, Pace Analytical Services, LLC, Precision Medicine Group, LLC, Quest Diagnostics Incorporated, REPROCELL Inc., SGS S.A., Shanghai Clinical Research Center, SMS Pharmaceuticals Ltd., Sonic Healthcare International, Syngene International Limited, Thermo Fisher Scientific Inc., Unilabs AB, Versiti, Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Central Lab Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Service Type
    • Anatomic Pathology/Histology
    • Biomarker Services
    • Genetic Services
    • Microbiology Services
    • Special Chemistry Services
    • Specimen Management & Storage
  • Phase
    • Phase 1
    • Phase 2
    • Phase 3
  • Therapeutic Area
    • Autoimmune Diseases
    • Cardiovascular Diseases
    • Infectious Diseases
    • Neurology
    • Oncology
  • End-use
    • Academic & Research Institutes
    • Biotechnology Companies
    • Pathology & Diagnostic Lab
    • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the number of clinical trials and complexity of drug development activities
5.1.1.2. Government initiatives promoting precision medicine worldwide
5.1.2. Restraints
5.1.2.1. High cost of set-up and maintenance of central labs
5.1.3. Opportunities
5.1.3.1. Technological integrations and smart features in central labs
5.1.3.2. Investments for establishment and expansion of central labs
5.1.4. Challenges
5.1.4.1. Operational limitations and standardization complexities
5.2. Market Segmentation Analysis
5.2.1. Services Type: Preference for central labs for long-term storage of biological samples under controlled conditions for specific management
5.2.2. Phase: Integral role of the central labs for the execution of the entire clinical trial process
5.2.3. End-use: Need to facilitate seamless clinical trials, ensuring data integrity and operational excellence for pharmaceutical companies
5.2.4. Therapeutic Area: Comprehensive diagnostic and prognostic testing for oncology and infectious diseases therapeutic areas
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Central Lab Market, by Service Type
6.1. Introduction
6.2. Anatomic Pathology/Histology
6.3. Biomarker Services
6.4. Genetic Services
6.5. Microbiology Services
6.6. Special Chemistry Services
6.7. Specimen Management & Storage
7. Central Lab Market, by Phase
7.1. Introduction
7.2. Phase 1
7.3. Phase 2
7.4. Phase 3
8. Central Lab Market, by Therapeutic Area
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Cardiovascular Diseases
8.4. Infectious Diseases
8.5. Neurology
8.6. Oncology
9. Central Lab Market, by End-use
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Biotechnology Companies
9.4. Pathology & Diagnostic Lab
9.5. Pharmaceutical Companies
10. Americas Central Lab Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Central Lab Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Central Lab Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Medpace Central Labs Expand Singapore Facility
13.3.2. Vial Announces Collaborative Alliance with MLM Medical Labs for offering Central Laboratory Solutions
13.3.3. Cerba HealthCare to Acquire Canadian Contract Research Laboratory CIRION BioPharma Research to Expand Bioanalytical Capabilities and Shorten Time-to-Deploy Complex Clinical Trials
13.3.4. Cleveland Clinic and LabConnect announce Strategic Alliance for Improved Patient Care
13.3.5. Versiti Acquires Indiana-based Quantigen for Accelerating Pace of Innovation for Preclinical Research Services
13.3.6. Labor Dr. Wisplinghoff and Labconnect Announce Strategic Alliance - Expanding Global Central Laboratory Services to Accelerate the Development of Medicines
13.3.7. IQVIA & (RED) Announce Groundbreaking Partnership to Support Laboratory System Strengthening
13.3.8. Cerba Research Offers a Customized, Innovative Approach to its Partners in the Laboratory Services
13.3.9. Medpace Central Labs Expand Histology & Anatomic Pathology Services
13.3.10. Thermo Fisher to invest USD 59 Million for Clinical Research Lab Expansion in the U.S.
List of Figures
FIGURE 1. CENTRAL LAB MARKET RESEARCH PROCESS
FIGURE 2. CENTRAL LAB MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CENTRAL LAB MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CENTRAL LAB MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CENTRAL LAB MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CENTRAL LAB MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES CENTRAL LAB MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES CENTRAL LAB MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. CENTRAL LAB MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. CENTRAL LAB MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CENTRAL LAB MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CENTRAL LAB MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CENTRAL LAB MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CENTRAL LAB MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CENTRAL LAB MARKET DYNAMICS
TABLE 7. GLOBAL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CENTRAL LAB MARKET SIZE, BY ANATOMIC PATHOLOGY/HISTOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CENTRAL LAB MARKET SIZE, BY BIOMARKER SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CENTRAL LAB MARKET SIZE, BY GENETIC SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CENTRAL LAB MARKET SIZE, BY MICROBIOLOGY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CENTRAL LAB MARKET SIZE, BY SPECIAL CHEMISTRY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CENTRAL LAB MARKET SIZE, BY SPECIMEN MANAGEMENT & STORAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 1, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 2, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 3, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CENTRAL LAB MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CENTRAL LAB MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CENTRAL LAB MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CENTRAL LAB MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CENTRAL LAB MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CENTRAL LAB MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CENTRAL LAB MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CENTRAL LAB MARKET SIZE, BY PATHOLOGY & DIAGNOSTIC LAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CENTRAL LAB MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CENTRAL LAB MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 42. CANADA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 43. CANADA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 44. CANADA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 45. CANADA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 49. MEXICO CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CENTRAL LAB MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 64. CHINA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 65. CHINA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 66. CHINA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 67. CHINA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 68. INDIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 69. INDIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 70. INDIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 71. INDIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 73. INDONESIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 75. INDONESIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 76. JAPAN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 77. JAPAN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 78. JAPAN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 79. JAPAN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 81. MALAYSIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 82. MALAYSIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 83. MALAYSIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 85. PHILIPPINES CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 86. PHILIPPINES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 87. PHILIPPINES CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 89. SINGAPORE CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 90. SINGAPORE CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 91. SINGAPORE CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 93. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 94. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 95. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 97. TAIWAN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 98. TAIWAN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 99. TAIWAN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 100. THAILAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 101. THAILAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 102. THAILAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 103. THAILAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 105. VIETNAM CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 106. VIETNAM CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 107. VIETNAM CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 113. DENMARK CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 114. DENMARK CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 115. DENMARK CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 116. DENMARK CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 117. EGYPT CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 118. EGYPT CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 119. EGYPT CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 120. EGYPT CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 121. FINLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 122. FINLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 123. FINLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 124. FINLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 125. FRANCE CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 126. FRANCE CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 127. FRANCE CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 128. FRANCE CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 129. GERMANY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 130. GERMANY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 131. GERMANY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 132. GERMANY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 134. ISRAEL CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 135. ISRAEL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 136. ISRAEL CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 137. ITALY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 138. ITALY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 139. ITALY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 140. ITALY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 144. NETHERLANDS CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 146. NIGERIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 147. NIGERIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 148. NIGERIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 149. NORWAY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 150. NORWAY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 151. NORWAY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 152. NORWAY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 153. POLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 154. POLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 155. POLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 156. POLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 157. QATAR CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 158. QATAR CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 159. QATAR CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 160. QATAR CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 173. SPAIN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 174. SPAIN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 175. SPAIN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 176. SPAIN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 182. SWITZERLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 183. SWITZERLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 184. SWITZERLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 185. TURKEY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 186. TURKEY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 187. TURKEY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 188. TURKEY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 197. CENTRAL LAB MARKET SHARE, BY KEY PLAYER, 2023
TABLE 198. CENTRAL LAB MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Central Lab market, which are profiled in this report, include:
  • ACM Medical Laboratory, Inc.
  • Almac Group
  • Cerba HealthCare
  • CROMSOURCE by ClinChoice
  • Cryoport, Inc.
  • Eurofins Scientific SE
  • Exagen Inc.
  • Frontage Laboratories, Inc.
  • GBA Group
  • GCCL Co., Ltd.
  • ICON PLC
  • InterlabCorp
  • Intertek Group PLC
  • IQVIA Inc.
  • LabConnect, Inc.
  • Laboratory Corporation of America Holdings
  • Lambda Therapeutic Research Ltd.
  • Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd.
  • MDS Pharma Services
  • Medicover AB
  • Medpace, Inc.
  • MLM Medical Labs GmbH
  • Novotech Health Holdings
  • Pace Analytical Services, LLC
  • Precision Medicine Group, LLC
  • Quest Diagnostics Incorporated
  • REPROCELL Inc.
  • SGS S.A.
  • Shanghai Clinical Research Center
  • SMS Pharmaceuticals Ltd.
  • Sonic Healthcare International
  • Syngene International Limited
  • Thermo Fisher Scientific Inc.
  • Unilabs AB
  • Versiti, Inc.
  • WuXi AppTec

Methodology

Loading
LOADING...

Table Information